logo conference-reports

Hasil Konferensi

Educational funding by logo MSD Oncology

BLOOD 2019 – Early light chain kinetics is highly predictive of renal response to carfilzomib in myeloma with renal impairment – ALLG MM16 trial

A medication strategy to improve outcomes of myeloma patients with poor renal outcomes